{"name":"Millennium Pharmaceuticals","permalink":"millennium-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/millennium-pharmaceuticals","homepage_url":"http://www.mlnm.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":966,"founded_year":1993,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@mlnm.com","phone_number":"800-390-5663","description":"Biopharm research","created_at":"Mon Sep 07 10:20:49 UTC 2009","updated_at":"Thu Jul 14 13:51:41 UTC 2011","overview":"<p>Millennium Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of medicines for the treatment of cancer in the United States and internationally. It develops and markets VELCADE for injection, a cancer therapy for the treatment of patients with multiple myeloma and relapsed mantle cell lymphoma. </p>\n\n<p>The company was founded in 1993 and is headquartered in Cambridge, Massachusetts with facilities in San Diego, San Francisco, Tsukuba, and Osaka. </p>\n\n<p>As of May 13, 2008, Millennium Pharmaceuticals, Inc. operates as a subsidiary of Takeda Pharmaceutical Co. Ltd.</p>","image":{"available_sizes":[[[150,51],"assets/images/resized/0005/8968/58968v1-max-150x150.png"],[[177,61],"assets/images/resized/0005/8968/58968v1-max-250x250.png"],[[177,61],"assets/images/resized/0005/8968/58968v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Deborah","last_name":"Dunsire","permalink":"deborah-dunsire","image":null}},{"is_past":false,"title":"CFO","person":{"first_name":"Marsha","last_name":"H. Fanucci","permalink":"marsha-h-fanucci","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[],"acquisition":{"price_amount":8689310000,"price_currency_code":"USD","term_code":null,"source_url":"http://www.takeda.com/press/article_29939.html","source_description":"Takeda Completes Acquisition of Millennium","acquired_year":2008,"acquired_month":2,"acquired_day":1,"acquiring_company":{"name":"Takeda Pharmaceutical","permalink":"takeda-pharmaceutical","image":{"available_sizes":[[[82,32],"assets/images/resized/0005/9044/59044v2-max-150x150.png"],[[82,32],"assets/images/resized/0005/9044/59044v2-max-250x250.png"],[[82,32],"assets/images/resized/0005/9044/59044v2-max-450x450.png"]],"attribution":null}}},"acquisitions":[],"offices":[{"description":"","address1":"40 Landsdowne Street","address2":"","zip_code":"02139","city":"Cambridge","state_code":"MA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[{"description":"submitted two supplemental new drug applications (NDAs) for Velcade, a cancer treatment, to the U.S. Food and Drug Administration","stoned_year":2011,"stoned_month":4,"stoned_day":26,"source_url":"http://www.masshightech.com/stories/2011/04/25/daily23-Millennium-submits-supplemental-NDAs-on-cancer-drug.html","source_text":null,"source_description":"Millennium submits supplemental NDAs on cancer drug","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Millennium Pharmaceuticals","permalink":"millennium-pharmaceuticals"}}],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}